Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α.
第一作者:
James N,Ingle
第一单位:
Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota. ingle.james@mayo.edu wang.liewei@mayo.edu.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);乳腺肿瘤(Breast Neoplasms);病例对照研究(Case-Control Studies);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);临床试验, Ⅳ期(主题)(Clinical Trials, Phase IV as Topic);雌激素受体α(Estrogen Receptor alpha);雌激素类(Estrogens);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);中年人(Middle Aged);多中心研究(主题)(Multicenter Studies as Topic);预后(Prognosis);前瞻性研究(Prospective Studies);随机对照试验(主题)(Randomized Controlled Trials as Topic)
DOI
10.1158/1078-0432.CCR-19-3091
PMID
32098767
发布时间
2021-09-13
- 浏览0

Clinical cancer research
2986-2996页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文